Sequential Ubiquitination and Deubiquitination Enzymes Synchronize the Dual Sensor and Effector Functions of TRIM21

Total Page:16

File Type:pdf, Size:1020Kb

Sequential Ubiquitination and Deubiquitination Enzymes Synchronize the Dual Sensor and Effector Functions of TRIM21 Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21 Adam J. Fletcher1, Donna L. Mallery, Ruth E. Watkinson, Claire F. Dickson, and Leo C. James1 Division of Protein and Nucleic Acid Chemistry, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom Edited by Jeremy Luban, University of Massachusetts Medical School, Worcester, Massachusetts, and accepted by the Editorial Board June 15, 2015 (received for review April 17, 2015) Tripartite motif (TRIM) 21 is a cytosolic antibody receptor that Ub ligase (E3), and the Ub-erasing deubiquitinase (DUB). Of neutralizes antibody-coated viruses that penetrate the cell and these, the E2 plays a central role in selecting the Ub chain simultaneously activates innate immunity. Here we show that the linkage topology (9–11). For example, the heterodimeric RING- conjugation of TRIM21 with K63-linked ubiquitin (Ub-63Ub) cata- domain E3 ligase BRCA1-BARD1 auto-monoubiquitinates us- lyzed by the sequential activity of nonredundant E2 Ub enzymes ing one of the E2s UbcH6, Ube2E2, UbcM2, or Ube2W, and is required for its dual antiviral functions. TRIM21 is first labeled the monoUb can be extended into Ub-63Ub or Ub-48Ub by with monoubiquitin (monoUb) by the E2 Ube2W. The monoUb is Ube2N/UbeV2 or Ube2K, respectively (12). PolyUb is typically a substrate for the heterodimeric E2 Ube2N/Ube2V2, resulting in attached to a substrate by the E3; however, with some proclivity, 63 63 TRIM21-anchored Ub- Ub. Depletion of either E2 abolishes Ub- Ub E3–E2 pairs can also generate unanchored polyUb chains 48 and Ub- Ub conjugation of TRIM21, NF-κB signaling, and virus neu- in vitro (13). Unanchored polyUb has been shown to activate 63 tralization. The formation of TRIM21-Ub- Ub precedes proteasome innate immune signaling (4, 5, 8, 14), but how it is generated and recruitment, and we identify an essential role for the 19S-resident regulated in cells remains poorly understood. and degradation-coupled deubiquitinase Poh1 in TRIM21 neutraliza- Once a Ub-modified substrate arrives at the proteasome, three tion, signaling, and cytokine induction. This study elucidates a com- DUBs in the 19S regulatory particle (RP), Usp14/Ubp6, Uch37/ plex mechanism of step-wise ubiquitination and deubiquitination UCHL5, and Rpn11/Poh1, trim or remove Ub modifications activities that allows contemporaneous innate immune signaling before substrate degradation (15). Although Ub-48Ub is a ca- and neutralization by TRIM21. nonical degradation signal, both Ub-48Ub and Ub-63Ub are hy- drolyzed by purified proteasomes in vitro (16, 17), and some TRIM21 | NF-kB | Ube2W | Ube2N/Ube2V2 | Poh1 studies have observed Ub-63Ub specificity in the polyUb ampu- tation activity of Poh1 (18, 19). Whether Ub-63Ub has a role at RIM21 is a cytoplasmic Ig receptor belonging to the tripartite the proteasome remains unclear; its presence at this location Tmotif family of E3 ubiquitin (Ub) ligases. Many TRIM pro- would seem incongruous with a model in which only Ub-48Ub- ∼ teins (there are 100 members in humans) have reported roles in labeled proteins are genuine substrates (20, 21). innate immunity (1). TRIM21 intercepts incoming, cytoplasmic In this report, we show that the effector and sensor functions antibody-coated pathogens and neutralizes them by mediating of TRIM21 are dependent on its sequential recruitment of the their VCP- and proteasome-dependent degradation (2, 3). In E2s Ube2W and Ube2N/Ube2V2, and the DUB Poh1. addition, TRIM21 initiates a signaling cascade, resulting in the transcriptional up-regulation of inflammatory cytokines and a Significance potent antiviral state in surrounding cells (4). Such antiviral du- ality has also been reported for a paralogue of TRIM21, TRIM5α (5), and more recently, TRIM19/PML (6), suggesting that an ability Tripartite motif (TRIM) proteins are a large family of E3 ubiq- to “sense” and neutralize viral infection is a conserved TRIM uitin (Ub) ligases, with many members having important roles function. The mechanism by which a TRIM protein coordinates in innate immunity. TRIM21 is a cytosolic antibody receptor sensor and effector functions remains unknown. that recognizes the Fc portion of antibodies bound to incoming For TRIM21, these dual functions are dependent upon its virions. On binding to these immune complexes, TRIM21 trig- activity as an E3 Ub ligase. In previous work, we have shown gers the catastrophic disassembly of viral capsids at the pro- that the TRIM21 really interesting new gene (RING) domain is teasome, terminating viral infection. Simultaneously, TRIM21 “ ” required for neutralization and catalyzes autoubiquitination senses the presence of the virus and provokes signaling κ with K48-linked polyubiquitin (polyUb) (Ub-48Ub, following cascades that activate the transcription factor NF- B, ultimately the nomenclature suggested by ref. 7) in vitro (3), suggesting alerting surrounding cells to the infection. Here, we uncover TRIM21 might synthesize Ub-48Ub to recruit the proteasome. the stepwise ubiquitination mechanism catalyzed by TRIM21, We also demonstrated that TRIM21, with the heterodimeric E2 as well as the various cofactors required, that allows these two enzyme Ube2N/Ube2V1, catalyses the formation of unanchored antiviral activities to occur synchronously at the proteasome. K63-linked polyUb (Ub-63Ub) in vitro (4). Ube2N and Ub-63Ub were essential for TRIM21 to mount an innate signaling re- Author contributions: A.J.F., D.L.M., R.E.W., and L.C.J. designed research; A.J.F., D.L.M., 63 and R.E.W. performed research; A.J.F., D.L.M., R.E.W., and C.F.D. contributed new re- sponse, consistent with a role for unanchored Ub- Ub in NF-κB agents/analytic tools; A.J.F., D.L.M., R.E.W., C.F.D., and L.C.J. analyzed data; and A.J.F. signaling (8). Thus, the ability of TRIM21 to mediate multiple and L.C.J. wrote the paper. functions seems associated with its ability to synthesize mul- The authors declare no conflict of interest. tiple Ub chain types. Moreover, because TRIM21 only initiates This article is a PNAS Direct Submission. J.L. is a Guest Editor invited by the Editorial Board. innate signaling upon recognition of antibody-bound virus (4), See Commentary on page 9797. this suggests that the effector and sensor functions of TRIM21 1To whom correspondence may be addressed. Email: [email protected] or lcj@ are mechanistically connected. mrc-lmb.cam.ac.uk. Four enzymes are involved in the ubiquitination cycle: the Ub This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. activating (E1), the Ub conjugating (E2), the substrate-specifying 1073/pnas.1507534112/-/DCSupplemental. 10014–10019 | PNAS | August 11, 2015 | vol. 112 | no. 32 www.pnas.org/cgi/doi/10.1073/pnas.1507534112 Downloaded by guest on September 25, 2021 Results substrates with anchored Ub-63Ub chains (12, 22), we depleted Ube2W and Ube2N Are Required for TRIM21 Dual Effector and Sensor Ube2W, using shRNA, to ask whether it too has a role in virus SEE COMMENTARY Functions. Previously, we have shown that infection of non- neutralization. Interestingly, Ube2W depletion also reversed professional cells with antibody-coated adenovirus (AdV:Ab) neutralization of adenovirus by 9C12 (Fig. 1C), suggesting both results in TRIM21-dependent NF-κB activation and proteasome- Ube2W and Ube2N/Ube2V2 are cofactors for TRIM21-medi- mediated virus neutralization (4). To investigate the functional ated virus neutralization. Furthermore, we observed that Ube2W relationship between these two antiviral outcomes, we first asked depletion abolished potent activation of NF-κB-Luc on challenge whether the generation of an innate immune response via NF-κB with Adv:Ab (Fig. 1D). In contrast, we measured no decrease in κ α activation precedes virus destruction by the proteasome. We NF- B-Luc activation in response to TNF in Ube2W-depleted treated human TE671 cells with chemical inhibitors of the pro- cells (Fig. 1E). Western blots confirmed depletions of Ube2N (Fig. teasome (MG132, bortezomib) or NF-κB signaling (5Z-7-Oxo- 1F), and RT-qPCR confirmed depletions of Ube2W (Fig. 1G). zeaenol, IKK Inhibitor VII). As shown in Fig. 1A, 7-h treatment of Together, these experiments suggest Ube2N and Ube2W are human TE671 cells with MG132, bortezomib, IKK VII, or 5Z-7- nonredundant cofactors for both sensing and effector responses of κ TRIM21, an unexpected observation because Ube2W is reported Oxozeaenol inhibited the stimulation of a model NF- Bpromoter 63 that drives luciferase expression (NF-κB-Luc) after infection with to anchor polyUb to substrates (22, 23) and Ub- Ub chains are AdV:Ab. However, although both MG132 and bortezomib not thought to recruit proteins to the proteasome (17). inhibited virus neutralization by the monoclonal antihexon anti- body 9C12 (Fig. 1B), IKK inhibitor VII or 5Z-7-Oxozeaenol did Ube2W Monoubiquitinates TRIM21. We next investigated whether not. Thus, TRIM21-dependent NF-κB activation is not a requisite TRIM21 can act as an E3 enzyme for Ube2W. We expressed for virus neutralization, suggesting signaling and neutralization full-length TRIM21 bearing an N-terminal MBP tag that im- might be synchronous, rather than sequential. proved protein solubility. We incubated purified MBP-TRIM21 To test this idea, we considered whether TRIM21 ubiquiti- with E1, Ube2W, and Ub. As increasing amounts of Ube2W nation, as required for innate signaling, was also required for were titrated into the reactions, we observed an increase in modified MBP-TRIM21 (Fig. 2A, Top). Probing with an anti-Ub virus neutralization. In vitro, TRIM21 synthesizes unanchored 63 63 antibody revealed a band of the same size as modified MBP- Ub- Ub in the presence of Ube2N/Ube2V1, and both Ub- Ub TRIM21, suggesting the adduct was a monoUb (Fig. 2A, Bot- and Ube2N are necessary for TRIM21 to provoke an innate tom). There were additional bands in the Ub blot with sizes immune signal (4).
Recommended publications
  • Ubiquitin-Conjugating Enzyme UBE2J1 Negatively Modulates
    Feng et al. Virology Journal (2018) 15:132 https://doi.org/10.1186/s12985-018-1040-5 RESEARCH Open Access Ubiquitin-conjugating enzyme UBE2J1 negatively modulates interferon pathway and promotes RNA virus infection Tingting Feng1, Lei Deng1, Xiaochuan Lu1, Wen Pan1, Qihan Wu2* and Jianfeng Dai1,2* Abstract Background: Viral infection activates innate immune pathways and interferons (IFNs) play a pivotal role in the outcome of a viral infection. Ubiquitin modifications of host and viral proteins significantly influence the progress of virus infection. Ubiquitin-conjugating enzyme E2s (UBE2) have the capacity to determine ubiquitin chain topology and emerge as key mediators of chain assembly. Methods: In this study, we screened the functions of 34 E2 genes using an RNAi library during Dengue virus (DENV) infection. RNAi and gene overexpression approaches were used to study the gene function in viral infection and interferon signaling. Results: We found that silencing UBE2J1 significantly impaired DENV infection, while overexpression of UBE2J1 enhanced DENV infection. Further studies suggested that type I IFN expression was significantly increased in UBE2J1 silenced cells and decreased in UBE2J1 overexpressed cells. Reporter assay suggested that overexpression of UBE2J1 dramatically suppressed RIG-I directed IFNβ promoter activation. Finally, we have confirmed that UBE2J1 can facilitate the ubiquitination and degradation of transcription factor IFN regulatory factor 3 (IRF3). Conclusion: These results suggest that UBE2 family member UBE2J1 can negatively regulate type I IFN expression, thereby promote RNA virus infection. Keywords: UBE2J1, Dengue virus, Interferons, IRF3, K48 ubiquitination Background antiviral responses [3]. IFN-α/β regulates the synthesis Dengue virus (DENV), transmitted by Aedes aegypti and of antiviral proteins and immunoregulatory factors Aedes albopicuts, causes an emerging tropical disease through the JAK/STAT signaling pathway [4, 5].
    [Show full text]
  • The HECT Domain Ubiquitin Ligase HUWE1 Targets Unassembled Soluble Proteins for Degradation
    OPEN Citation: Cell Discovery (2016) 2, 16040; doi:10.1038/celldisc.2016.40 ARTICLE www.nature.com/celldisc The HECT domain ubiquitin ligase HUWE1 targets unassembled soluble proteins for degradation Yue Xu1, D Eric Anderson2, Yihong Ye1 1Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA; 2Advanced Mass Spectrometry Core Facility, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA In eukaryotes, many proteins function in multi-subunit complexes that require proper assembly. To maintain complex stoichiometry, cells use the endoplasmic reticulum-associated degradation system to degrade unassembled membrane subunits, but how unassembled soluble proteins are eliminated is undefined. Here we show that degradation of unassembled soluble proteins (referred to as unassembled soluble protein degradation, USPD) requires the ubiquitin selective chaperone p97, its co-factor nuclear protein localization protein 4 (Npl4), and the proteasome. At the ubiquitin ligase level, the previously identified protein quality control ligase UBR1 (ubiquitin protein ligase E3 component n-recognin 1) and the related enzymes only process a subset of unassembled soluble proteins. We identify the homologous to the E6-AP carboxyl terminus (homologous to the E6-AP carboxyl terminus) domain-containing protein HUWE1 as a ubiquitin ligase for substrates bearing unshielded, hydrophobic segments. We used a stable isotope labeling with amino acids-based proteomic approach to identify endogenous HUWE1 substrates. Interestingly, many HUWE1 substrates form multi-protein com- plexes that function in the nucleus although HUWE1 itself is cytoplasmically localized. Inhibition of nuclear entry enhances HUWE1-mediated ubiquitination and degradation, suggesting that USPD occurs primarily in the cytoplasm.
    [Show full text]
  • Identification of the Binding Partners for Hspb2 and Cryab Reveals
    Brigham Young University BYU ScholarsArchive Theses and Dissertations 2013-12-12 Identification of the Binding arP tners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non- Redundant Roles for Small Heat Shock Proteins Kelsey Murphey Langston Brigham Young University - Provo Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Microbiology Commons BYU ScholarsArchive Citation Langston, Kelsey Murphey, "Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins" (2013). Theses and Dissertations. 3822. https://scholarsarchive.byu.edu/etd/3822 This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactions and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston A thesis submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Master of Science Julianne H. Grose, Chair William R. McCleary Brian Poole Department of Microbiology and Molecular Biology Brigham Young University December 2013 Copyright © 2013 Kelsey Langston All Rights Reserved ABSTRACT Identification of the Binding Partners for HspB2 and CryAB Reveals Myofibril and Mitochondrial Protein Interactors and Non-Redundant Roles for Small Heat Shock Proteins Kelsey Langston Department of Microbiology and Molecular Biology, BYU Master of Science Small Heat Shock Proteins (sHSP) are molecular chaperones that play protective roles in cell survival and have been shown to possess chaperone activity.
    [Show full text]
  • A Drosophila Ortholog of the Human Cylindromatosis Tumor Suppressor
    RESEARCH ARTICLE 2605 Development 134, 2605-2614 (2007) doi:10.1242/dev.02859 A Drosophila ortholog of the human cylindromatosis tumor suppressor gene regulates triglyceride content and antibacterial defense Theodore Tsichritzis1, Peer C. Gaentzsch3, Stylianos Kosmidis2, Anthony E. Brown3, Efthimios M. Skoulakis2, Petros Ligoxygakis3,* and George Mosialos1,4,* The cylindromatosis (CYLD) gene is mutated in human tumors of skin appendages. It encodes a deubiquitylating enzyme (CYLD) that is a negative regulator of the NF-␬B and JNK signaling pathways, in vitro. However, the tissue-specific function and regulation of CYLD in vivo are poorly understood. We established a genetically tractable animal model to initiate a systematic investigation of these issues by characterizing an ortholog of CYLD in Drosophila. Drosophila CYLD is broadly expressed during development and, in adult animals, is localized in the fat body, ovaries, testes, digestive tract and specific areas of the nervous system. We demonstrate that the protein product of Drosophila CYLD (CYLD), like its mammalian counterpart, is a deubiquitylating enzyme. Impairment of CYLD expression is associated with altered fat body morphology in adult flies, increased triglyceride levels and increased survival under starvation conditions. Furthermore, flies with compromised CYLD expression exhibited reduced resistance to bacterial infections. All mutant phenotypes described were reversible upon conditional expression of CYLD transgenes. Our results implicate CYLD in a broad range of functions associated with fat homeostasis and host defence in Drosophila. KEY WORDS: Cylindromatosis, Drosophila, Fat body, Host defense, NF-kappaB INTRODUCTION disease and it is required for the proper development of T Familial cylindromatosis is an autosomal-dominant predisposition lymphocytes in mice (Costello et al., 2005; Reiley et al., 2006).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Cytosolic Fc Receptor TRIM21 Inhibits Seeded Tau Aggregation
    Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation William A. McEwana,1, Benjamin Falcona, Marina Vaysburda, Dean Clifta, Adrian L. Oblakb, Bernardino Ghettib, Michel Goederta,1, and Leo C. Jamesa,1 aMedical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom; and bDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202 Edited by Alexander Espinosa, Karolinska Institutet, Stockholm, Sweden, and accepted by Editorial Board Member Stephen P. Goff December 6, 2016 (received for review May 6, 2016) Alzheimer’s disease (AD) and other neurodegenerative disorders assemblies into the brains of tau transgenic mice promotes the are associated with the cytoplasmic aggregation of microtubule- aggregation of intracellular tau (7), and ectopic addition of associated protein tau. Recent evidence supports transcellular recombinant tau assemblies promotes the aggregation of in- transfer of tau misfolding (seeding) as the mechanism of spread tracellular pools in cultured cells (8, 9). Consistent with trans- within an affected brain, a process reminiscent of viral infection. cellular propagation of misfolding, tau pathology in AD spreads However, whereas microbial pathogens can be recognized as non- between connected regions of the brain in a stereotyped manner self by immune receptors, misfolded protein assemblies evade detec- (10). Seeded propagation of misfolded tau is therefore proposed tion, as they are host-derived. Here, we show that when misfolded to underlie many common neurodegenerative disorders. Akin to tau assemblies enter the cell, they can be detected and neutralized via viral infection, this model of seeded tau propagation relies on the a danger response mediated by tau-associated antibodies and the physical transfer of tau assemblies between cells, and is therefore cytosolic Fc receptor tripartite motif protein 21 (TRIM21).
    [Show full text]
  • Material Data Sheet
    MATERIAL DATA SHEET Recombinant Human His6 UBE2N/UBE2V2 Complex Cat. # E2­666 Ubiquitin conjugating Enzyme E2N (UBE2N), also known as Ubiquitin conjugating Enzyme 13 (Ubc13), forms a functional complex with the catalytically inactive UBE2V2 (human homologue of yeast MMS2) protein (1). Human UBE2N/Ubc13 shares 100% and 99% amino acid (aa) sequence identity with the mouse and rat orthologs, respectively, while human UBE2V2 shares 99% aa sequence identity with its mouse and rat orthologs. The UBE2N/UBE2V2 Complex functions with Ubiquitin ligases (E3s), including RNF111 and RNF8, to synthesize Lys63­linked Ubiquitin chains (2,3) that can either be unanchored or attached to target proteins (4, 5). The UBE2N/UBE2V2 complex has important roles in facilitating responses to various forms of DNA damage (2, 6). Product Information Quantity: 100 µg | 50 µg MW: 18 kDa (UBE2N), 17 kDa (UBE2V2) Source: E. coli­derived Contains an N­terminal 6­His tag Accession # P61088 (UBE2N)/Q15819 (UBE2V2) Stock: 0.88 mg/ml (25 μM) in 50 mM HEPES pH 7.5, 200 mM NaCl, 10% Glycerol (v/v), 2 mM TCEP Purity: >95%, by SDS­PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain. Rev. 5/22/2014 Page 1 of 2 www.bostonbiochem.com Boston Biochem products are available via the R&D Systems distributor network. USA & CANADA Tel: (800) 343-7475 EUROPE Tel: +44 (0)1235 529449 CHINA Tel: +86 (21) 52380373 Use & Storage Use: Recombinant Human His6­UBE2N/UBE2V2 Complex is a member of the Ubiquitin conjugating (E2) enzyme family that receives Ubiquitin from a Ubiquitin activating (E1) enzyme and subsequently interacts with a Ubiquitin ligase (E3) to conjugate Ubiquitin to substrate proteins.
    [Show full text]
  • The Ubiquitination Enzymes of Leishmania Mexicana
    The ubiquitination enzymes of Leishmania mexicana Rebecca Jayne Burge Doctor of Philosophy University of York Biology October 2020 Abstract Post-translational modifications such as ubiquitination are important for orchestrating the cellular transformations that occur as the Leishmania parasite differentiates between its main morphological forms, the promastigote and amastigote. Although 20 deubiquitinating enzymes (DUBs) have been partially characterised in Leishmania mexicana, little is known about the role of E1 ubiquitin-activating (E1), E2 ubiquitin- conjugating (E2) and E3 ubiquitin ligase (E3) enzymes in this parasite. Using bioinformatic methods, 2 E1, 13 E2 and 79 E3 genes were identified in the L. mexicana genome. Subsequently, bar-seq analysis of 23 E1, E2 and HECT/RBR E3 null mutants generated in promastigotes using CRISPR-Cas9 revealed that the E2s UBC1/CDC34, UBC2 and UEV1 and the HECT E3 ligase HECT2 are required for successful promastigote to amastigote differentiation and UBA1b, UBC9, UBC14, HECT7 and HECT11 are required for normal proliferation during mouse infection. Null mutants could not be generated for the E1 UBA1a or the E2s UBC3, UBC7, UBC12 and UBC13, suggesting these genes are essential in promastigotes. X-ray crystal structure analysis of UBC2 and UEV1, orthologues of human UBE2N and UBE2V1/UBE2V2 respectively, revealed a heterodimer with a highly conserved structure and interface. Furthermore, recombinant L. mexicana UBA1a was found to load ubiquitin onto UBC2, allowing UBC2- UEV1 to form K63-linked di-ubiquitin chains in vitro. UBC2 was also shown to cooperate with human E3s RNF8 and BIRC2 in vitro to form non-K63-linked polyubiquitin chains, but association of UBC2 with UEV1 inhibits this ability.
    [Show full text]
  • UBE2E2 Antibody Cat
    UBE2E2 Antibody Cat. No.: 29-870 UBE2E2 Antibody Antibody used in WB on recombin ant protein at: 1:500 (Lanes: 1: 40ng HIS- UBE2D1 protein, 2: 40ng HIS- UBE2D2 protein, 3: 40ng HIS- UBE2D3 proteinm, 4: 40ng HIS- UBE2D4 protein, 5: 40ng HIS- UBE2E1 protein, 6: Antibody used in WB on Human Jurkat 0.125 ug/ml. 40ng HIS- UBE2E2 protein, 7: 40ng HIS- UBE2E3 protein, 8: 40ng HIS- UBE2K protein, 9: 40ng HIS- UBE2L3 protein, 10: 40ng HIS- UBE2N protein, 11: 40ng HIS- UBE2V1 protein, 12: 40ng HIS- UBE2V2 protein.). September 24, 2021 1 https://www.prosci-inc.com/ube2e2-antibody-29-870.html Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Dog, Human, Mouse, Rat Antibody produced in rabbits immunized with a synthetic peptide corresponding a region IMMUNOGEN: of human UBE2E2. TESTED APPLICATIONS: ELISA, IHC, WB UBE2E2 antibody can be used for detection of UBE2E2 by ELISA at 1:1562500. UBE2E2 APPLICATIONS: antibody can be used for detection of UBE2E2 by western blot at 0.125 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000. POSITIVE CONTROL: 1) Cat. No. 1205 - Jurkat Cell Lysate PREDICTED MOLECULAR 22 kDa WEIGHT: Properties PURIFICATION: Antibody is purified by peptide affinity chromatography method. CLONALITY: Polyclonal CONJUGATE: Unconjugated PHYSICAL STATE: Liquid Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% BUFFER: sucrose. CONCENTRATION: batch dependent For short periods of storage (days) store at 4˚C. For longer periods of storage, store STORAGE CONDITIONS: UBE2E2 antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.
    [Show full text]
  • Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 As
    cells Article Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners 1, 1, 2, Eunate Gallardo-Vara y, Lidia Ruiz-Llorente y, Juan Casado-Vela y , 3 4 5 6, , María J. Ruiz-Rodríguez , Natalia López-Andrés , Asit K. Pattnaik , Miguel Quintanilla z * 1, , and Carmelo Bernabeu z * 1 Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain; [email protected] (E.G.-V.); [email protected] (L.R.-L.) 2 Bioengineering and Aerospace Engineering Department, Universidad Carlos III and Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Leganés, 28911 Madrid, Spain; [email protected] 3 Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain; [email protected] 4 Cardiovascular Translational Research, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, 31008 Pamplona, Spain; [email protected] 5 School of Veterinary Medicine and Biomedical Sciences, and Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68583, USA; [email protected] 6 Instituto de Investigaciones Biomédicas “Alberto Sols”, Consejo Superior de Investigaciones Científicas (CSIC), and Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), 28029 Madrid, Spain * Correspondence: [email protected] (M.Q.); [email protected] (C.B.) These authors contributed equally to this work. y Equal senior contribution. z Received: 7 August 2019; Accepted: 7 September 2019; Published: 13 September 2019 Abstract: Endoglin is a 180-kDa glycoprotein receptor primarily expressed by the vascular endothelium and involved in cardiovascular disease and cancer.
    [Show full text]
  • Supplementary Tables
    Supplementary Tables Supplementary Table S1: Preselected miRNAs used in feature selection Univariate Cox proportional hazards regression analysis of the endpoint freedom from recurrence in the training set (DKTK-ROG sample) allowed the pre-selection of 524 miRNAs (P< 0.5), which were used in the feature selection. P-value was derived from log-rank test. miRNA p-value miRNA p-value miRNA p-value miRNA p-value hsa-let-7g-3p 0.0001520 hsa-miR-1304-3p 0.0490161 hsa-miR-7108-5p 0.1263245 hsa-miR-6865-5p 0.2073121 hsa-miR-6825-3p 0.0004257 hsa-miR-4298 0.0506194 hsa-miR-4453 0.1270967 hsa-miR-6893-5p 0.2120664 hsa-miR-668-3p 0.0005188 hsa-miR-484 0.0518625 hsa-miR-200a-5p 0.1276345 hsa-miR-25-3p 0.2123829 hsa-miR-3622b-3p 0.0005885 hsa-miR-6851-3p 0.0531446 hsa-miR-6090 0.1278692 hsa-miR-3189-5p 0.2136060 hsa-miR-6885-3p 0.0006452 hsa-miR-1276 0.0557418 hsa-miR-148b-3p 0.1279811 hsa-miR-6073 0.2139702 hsa-miR-6875-3p 0.0008188 hsa-miR-3173-3p 0.0559962 hsa-miR-4425 0.1288330 hsa-miR-765 0.2141536 hsa-miR-487b-5p 0.0011381 hsa-miR-650 0.0564616 hsa-miR-6798-3p 0.1293342 hsa-miR-338-5p 0.2153079 hsa-miR-210-5p 0.0012316 hsa-miR-6133 0.0571407 hsa-miR-4472 0.1300006 hsa-miR-6806-5p 0.2173515 hsa-miR-1470 0.0012822 hsa-miR-4701-5p 0.0571720 hsa-miR-4465 0.1304841 hsa-miR-98-5p 0.2184947 hsa-miR-6890-3p 0.0016539 hsa-miR-202-3p 0.0575741 hsa-miR-514b-5p 0.1308790 hsa-miR-500a-3p 0.2185577 hsa-miR-6511b-3p 0.0017165 hsa-miR-4733-5p 0.0616138 hsa-miR-378c 0.1317442 hsa-miR-4515 0.2187539 hsa-miR-7109-3p 0.0021381 hsa-miR-595 0.0629350 hsa-miR-3121-3p
    [Show full text]
  • A Study on the E3 Ligase TRIM21/Ro52 Alexander Espinosa from the Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Thesis for doctoral degree (Ph.D.) 2008 Thesis for doctoral degree (Ph.D.) 2008 A STUDY ON THE E3 LIGASE TRIM21/RO52 A study on the E3 ligase TRIM21/Ro52 ligase E3 the on study A Alexander Espinosa Alexander Espinosa Fredrik Bredin From the Department of Medicine, Karolinska Institutet, Stockholm, Sweden A STUDY ON THE E3 LIGASE TRIM21/Ro52 Alexander Espinosa All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Larserics Digital Print AB, Box 20082, SE-161 02 Bromma, Sweden. © Alexander Espinosa, 2008 ISBN 978-91-7357-480-8 iii ABSTRACT Patients with the systemic autoimmune diseases Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE), often have antibodies against the intracellular protein TRIM21/Ro52. Although the presence of anti-TRIM21/Ro52 autoantibodies is used as a diagnostic tool, the biological function of TRIM21/Ro52 is still unknown. The aim of this thesis is to provide a better understanding of the function of TRIM21/Ro52, especially regarding its role in autoimmunity. To achieve this, TRIM21/Ro52 was studied at a molecular and cellular level in vitro and in vivo. By using circular dichroism, limited proteolysis, mass spectrometry, ultra-centrifugation, and two- hybrid experiments, it was shown that TRIM21/Ro52 is a Zn2+ binding protein that forms weak dimers. These results also confirmed the presence of the predicted secondary structure domains of TRIM21/Ro52. A RING domain in the N-terminus of TRIM21/Ro52 suggests that TRIM21/Ro52 is a RING dependent E3 ligase. Through ubiquitination assays, it was shown that TRIM/Ro52 is indeed an E3 ligase and that the E3 ligase activity of TRIM21/Ro52 was dependent on the E2 enzymes UbcH5a-c or UbcH6.
    [Show full text]